Phytoestrogens and their role in the management of postmenopausal osteoporosis

Southern Medical Journal

Volumn 102, Issue 1, 2009, Pages 111-112

  Lewiecki, E Michael ^a  

^a NEW MEXICO CLINICAL RESEARCH AND OSTEOPOROSIS CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CARBONATE; DEOXYPYRIDINOLINE; ESTROGEN; GENISTEIN; IPRIFLAVONE; PHYTOESTROGEN; PLACEBO; PYRIDINOLINE; RALOXIFENE; VITAMIN D;

BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; DRUG EFFECT; DRUG WITHDRAWAL; FEMUR NECK; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; LUMBAR SPINE; LYMPHOCYTOSIS; OSTEOLYSIS; OUTCOME ASSESSMENT; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; FEMALE; MIDDLE AGED;

FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOESTROGENS;

EID: 59249087786     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318188e315     Document Type: Letter

References (4)

1. Whelan AM, Jurgens TM, Bowles SK. Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials. Ann Pharmacother 2006;40:836-849.
2. Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 2002;17: 1904-1912.
3. Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone Multicenter European Fracture Study. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA 2001;285:1482-1488.
4. Marini H, Minutoli L, Polito F, et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 2007;146: 839-847.